InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Pelthos Therapeutics Inc.

PTHS Clue Score29
United States Fiscal year ends December CIK 0001919246 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Ligand Pharmaceuticals Inc
1 Jul 2025
10% owner
Exercised, kept
1,500,000
$10.00
$15.00M
Todd C Davis
1 Jul 2025
Director
Exercised, kept indirect
1,500,000
$10.00
$15.00M
Knuettel Francis II
1 Jul 2025
Chief Financial Officer
Exercised, kept indirect
10,000
$10.00
$100.00K
Ezra M Friedberg
1 Jul 2025
Director
Exercised, kept indirect
40,000
$10.00
$400.00K
Ezra M Friedberg
1 Jul 2025
Director
Exercised, kept indirect
40,000
$10.00
$400.00K
Ezra M Friedberg
21 Feb 2024
Director
Exercised, kept indirect
6,992
$4.80
$33.56K
Ezra M Friedberg
21 Feb 2024
Director
Exercised, kept indirect
13,649
$4.80
$65.52K
Todd C Davis
21 Feb 2024
Director
Exercised, kept
29,167
$4.80
$140.00K
Show all 39 transactions →

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 3,206,057
History held since 23 Feb 2024